AU6397796A - Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides - Google Patents

Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides

Info

Publication number
AU6397796A
AU6397796A AU63977/96A AU6397796A AU6397796A AU 6397796 A AU6397796 A AU 6397796A AU 63977/96 A AU63977/96 A AU 63977/96A AU 6397796 A AU6397796 A AU 6397796A AU 6397796 A AU6397796 A AU 6397796A
Authority
AU
Australia
Prior art keywords
peptides
protein
complement
modulating
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63977/96A
Inventor
Ronald T. Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Biology Institute
Original Assignee
Medical Biology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Biology Institute filed Critical Medical Biology Institute
Publication of AU6397796A publication Critical patent/AU6397796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU63977/96A 1995-06-29 1996-06-27 Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides Abandoned AU6397796A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US67495P 1995-06-29 1995-06-29
US000674 1995-06-29
US66361796A 1996-06-14 1996-06-14
US663617 1996-06-14
PCT/US1996/010958 WO1997001578A1 (en) 1995-06-29 1996-06-27 Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides

Publications (1)

Publication Number Publication Date
AU6397796A true AU6397796A (en) 1997-01-30

Family

ID=26667972

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63977/96A Abandoned AU6397796A (en) 1995-06-29 1996-06-27 Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides

Country Status (2)

Country Link
AU (1) AU6397796A (en)
WO (1) WO1997001578A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572589B2 (en) 2001-11-01 2009-08-11 The University Of British Columbia Diagnosis and treatment of infectious diseases through indel-differentiated proteins
US20030100016A1 (en) * 2001-11-23 2003-05-29 George Jackowski Complement C3 precursor biopolymer markers predictive of Alzheimers disease
GB0204154D0 (en) * 2002-02-22 2002-04-10 Adprotech Ltd Cat immunisation vectors
AR069130A1 (en) * 2007-11-02 2009-12-30 Novartis Ag LINK MOLECULES OF THE MAIN COMPLEMENT OPSONIN (C3B) AND METHODS TO MODULATE THE COMPLEMENT COMPONENT
CA2936346A1 (en) * 2014-01-08 2015-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibody targeting cell surface deposited complement protein c3d and use thereof
US11918624B2 (en) * 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305615A1 (en) * 1987-09-03 1989-03-08 Immunetech Pharmaceuticals, Inc. Peptide antagonists for the C5a anaphylatoxin
ATE94562T1 (en) * 1987-10-23 1993-10-15 Progen Biotechnik Gmbh ANTIGENIC PEPTIDES OF THE COMPLEMENT FACTOR C3A, USE OF THE PEPTIDES, CELL LINES, ANTIBODIES TO THE PEPTIDES AND USE OF THE ANTIBODIES.

Also Published As

Publication number Publication date
WO1997001578A1 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
AU5135996A (en) Systems and methods for identifying images
AU6381896A (en) Peptide library and screening method
AU3303797A (en) Method and system for protein modeling
AU6779994A (en) Method and system for protein modeling
AU2805995A (en) Combinatorial peptide library and method
AU6714796A (en) Method and apparatus for span and subspan sorting rendering system
AU7391296A (en) Method and apparatus for identifying and obtaining bottleneck cost information
AU5415796A (en) System and method for recycling materials
AU6058696A (en) Method and system for providing secure EDI over an open network
AU6584296A (en) Well completion system and method
AU7472196A (en) Alpha-helix mimetics and methods relating thereto
AU6232898A (en) Method and system for branch prediction
AU8644898A (en) System and method for handling permits
AU7035698A (en) Test system and test method
AU5445296A (en) Methods for preparing dna-binding proteins
AU5218296A (en) Multiple access system and method for multiple access
AU6854196A (en) Lighting apparatus and method
AU4413096A (en) Phenylalanine free proteins
AU7247896A (en) Protein signature analysis
AU6489996A (en) Methods for increasing protein expression
AU7294396A (en) Protein detection
AU2057895A (en) System and method for inspecting lenses
AU4394396A (en) Modified peptides
AU1811199A (en) System and method for plane selection
AU7571298A (en) Systems and methods for analyzing phantom images